Ovarian Cancer: Moving to a Personalized Treatment Approach

Автор: U.S. Food and Drug Administration

Загружено: 2024-12-17

Просмотров: 2183

Описание: The FDA Office of Women’s Health (OWH) hosted a free virtual webinar titled: Ovarian Cancer: Moving to a Personalized Treatment Approach presented by Dineo Khabele, MD, FACOG, FACS Mitchell & Elaine Yanow Professor and Chair, Department of Obstetrics & Gynecology Washington University School of Medicine. The webinar discussed high-grade serous ovarian cancer (HGSOC), the most common type of ovarian cancer and the presenter reviewed the challenges of early diagnosis and current treatment options for HGSOC.

Learn more about FDA OWH Public Meetings, Workshops, and Webinars: https://www.fda.gov/OWHmeetings.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...

Ovarian Cancer: Moving to a Personalized Treatment Approach

Доступные форматы для скачивания:

Скачать видео

Информация по загрузке:

Скачать аудио

Похожие видео

Sickle Cell Disease: A Spotlight on Women

Sickle Cell Disease: A Spotlight on Women

Medical Device Quality Management System Regulation Risk Management

Medical Device Quality Management System Regulation Risk Management

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Catching Up on Agency Reforms

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

Medical Device Quality Management System Regulation Design and Development

Medical Device Quality Management System Regulation Design and Development

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

FDA Direct: FDA Awards Six National Priority Vouchers

FDA Direct: FDA Awards Six National Priority Vouchers

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Resources for You and Your Baby

Resources for You and Your Baby

Know Your Pelvic Floor

Know Your Pelvic Floor

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

FDA-USP-AAM | D1S4 – Q&A Discussion Panel

FDA-USP-AAM | D1S4 – Q&A Discussion Panel